查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837172

尿失禁治疗设备市场按设备类型、材料、技术、性别、形态、年龄层、应用、最终用户和分销管道划分－全球预测，2025-2032年

Urinary Incontinence Device Market by Device Type, Material, Technology, Gender, Form, Age Group, Application, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，尿失禁治疗设备市场规模将达到 62.2 亿美元，复合年增长率为 7.60%。

关键市场统计数据
基准年2024年 34.6亿美元
预计年份：2025年 37.1亿美元
预测年份 2032 62.2亿美元
复合年增长率 (%) 7.60%

为指南尿失禁治疗设备相关人员，制定一个涵盖未满足的临床需求、不断变化的患者期​​望和多学科优先事项的策略框架。

本执行摘要首先聚焦于尿失禁医疗器材市场，重点阐述了临床负担、不断变化的患者期​​望以及应指南行业相关人员的策略重点。尿失禁不分年龄和性别，临床表现多样，需要各种保守治疗、微创治疗和植入式治疗方案。在整个治疗过程中，临床医生都在寻求兼顾疗效、患者舒适度和长期耐用性的器械，而采购和支付相关人员则越来越关注可验证的疗效和成本效益。

鑑于医疗器材创新日新月异，以及材料科学和数位医疗领域的同步发展，製造商和投资者必须以多学科视角审视产品开发。临床证据的产生、监管合规和报销途径共同建构了永续推广的框架。在此背景下，将可靠的临床检验与可扩展的生产製造和差异化的分销策略相结合的综合方法至关重要。因此，引言部分概述了可透过策略重点释放价值的关键领域，包括技术差异化、终端用户协作和弹性供应链设计，从而为本摘要的其余部分奠定了基础。

技术、人口结构和监管方面的变革性变化将重新定义尿失禁治疗设备的竞争优势和市场推广路径。

在技​​术、人口和政策等多面向因素的共同推动下，尿失禁治疗器材领域正经历多重变革。电刺激技术的进步、植入材料的改良以及机械部件的微型化，在提升器械性能的同时，也提高了病患的舒适度。同时，远端监测的兴起以及与行动医疗平台的整合，使得长期用药依从性追踪和对真实世界疗效的了解成为可能，这也为基于循证医学的医保报销提供了有力支持。

从人口结构来看，人口老化和对提升生活品质干预措施的广泛需求，正推动可靠、易用解决方案的临床应用。监管机构也正在调整审批流程，力求在确保患者及时获得治疗的同时，兼顾严格的安全评估，鼓励企业投资上市后监测和真实世界证据策略。此外，供应链韧性如今已成为管理层关注的焦点，促使企业重新评估对单一供应商的依赖，并推动了关于近岸外包的讨论。总而言之，这些转变正在重新定义竞争优势。那些兼具卓越工程技术和数据主导成果、稳健的监管规划以及敏捷的供应链能力的企业，很可能引领下一波应用浪潮。

2025年实施的关税政策变化将如何重塑泌尿失禁医疗器材价值链的采购、筹资策略和商业化动态？

2025年美国关税调整的累积影响将对尿失禁医疗器材生态系统产生重大影响，尤其是对那些依赖跨境供应链取得零件、成品和特殊材料的製造商而言。关税负担的增加将推高投入成本，挤压製造商的净利率，并可能促使他们重新思考筹资策略。为此，采购团队可能会寻求透过近岸外包、双重采购和重新谈判供应商合约来降低风险并保护利润。

除了直接的成本影响外，关税还可能影响产品设计和材料选择的策略决策，促使开发商转向替代方案，以减少对受关税影响的进口产品的依赖。经销商和医疗保健机构可能面临价格调整，这可能会延迟对成本敏感的领域（例如长期照护机构和门诊中心）的采购週期。同时，政策变化也可能为国内製造业的投资创造机会，从而缩短前置作业时间并提高品质监管水准。在临床方面，相关人员必须保持警惕，确保以成本主导的材料替代不会损害设备的安全性或性能，并确保监管文件反映设计和供应链的变化。总而言之，关税会促进更广泛的供应链转型，迫使相关人员调整筹资策略、临床检验和商业计划，以维护产品的可及性和价值。

将设备类型、材料选择、技术模式、患者人口统计特征和分销管道与临床应用和商业策略联繫起来的综合细分洞察

关键的细分洞察揭示了产品设计、材料科学、技术模式、目标族群、使用模式和通路偏好如何相互交织，共同塑造临床应用和市场机会。从器械类型来看，市场分为体外器械和体内器械，体外器械包括导尿管、收集器、输液收集器和阴茎夹，体内器械包括人工尿道括约肌、子宫托、荐椎神经刺激装置、尿道植入物和阴道吊带。关于材料选择，报告强调了乳胶、聚合物基材料和硅胶的重要性。

技术细分将电刺激设备与机械设备和外科植入分开来，从而影响临床试验设计和外科医生培训路径。性别特异性方法仍然至关重要，因为女性和男性患者的解剖结构和病因特征不同，这会影响设备的选择和治疗结果。区分抛弃式产品产品和可重复使用产品的外形规格会影响采购週期、消毒需求和环境永续性考量。成人和儿童族群的不同年龄层需要进行客製化的安全性和可用性测试。将临床用途分为功能性尿失禁、溢出性尿失禁、压力性尿失禁和急迫性尿失禁，既决定了产品规格，也决定了临床终点。最后，终端用户（门诊手术中心、家庭护理机构、医院/诊所和长期护理机构）与分销管道偏好（医院药房、线下药房和线上销售）的交集，决定了面向消费者的销售管道策略和售后支援需求。

美洲、欧洲、中东和非洲以及亚太地区的区域动态将影响监管策略、报销调整和分销重点。

区域动态对法规环境、报销系统和供应链架构有显着影响，进而决定企业如何优先投资以及如何调整其市场进入策略。在美洲，市场参与企业面临着多元化的支付方和高度的临床专业化，通常需要清晰的疗效数据、有针对性的关键意见领袖（KOL）互动以及弹性价格设定框架。放眼欧洲、中东和非洲，相关人员会遇到不同的监管要求和报销标准，而各国的具体路径和区域特定的临床证据则推动产品的推广应用。在这些地区的大部分地区，与当地经销商伙伴关係以及对采购週期进行谨慎管理对于市场准入至关重要。

亚太地区的特征是人口结构快速变化、监管成熟度差异显着以及製造业能力不断提升。该地区不断发展的医疗基础设施，以及对微创疗法的日益重视，为新产品的引入创造了机会，而本地化的製造能力则能带来成本优势和供应链韧性。由于亚太地区各地终端使用者行为、临床实践模式以及数位化医疗应对力存在差异，企业需要采取精细的商业策略，使产品设计、临床证据产生和经销伙伴与当地相关人员的期望相契合。

竞争格局、合作模式和创新管道正在塑造尿失禁治疗领域的领导地位和长期差异化优势。

在尿失禁医疗器材领域，各公司之间的竞争格局持续演变，其驱动力包括产品创新、策略伙伴关係和差异化的商业化模式。领先企业正投资于模组化设计策略，以实现迭代改进，同时保持监管的连续性。医疗器材製造商与数位医疗服务提供者之间的合作正在加速整合解决方案的开发，这些解决方案将机械疗法和植入式疗法与远端监测和依从性平台相结合，从而增强了对支付方和医疗服务提供方的价值提案。

併购和策略联盟仍然是扩大规模的重要途径，尤其是在能够整合互补的产品组合和地理布局以优化临床支援和分销的情况下。围绕新型材料、刺激演算法和微创给药系统所建构的智慧财产权组合是关键的竞争优势。同时，专注于创新的小型参与企业正在积极研发差异化产品，他们通常会利用针对特定适应症的临床项目来验证产品价值，然后再寻求更广泛的应用。对于商业性领导者而言，产品差异化、证据产生和通路策略之间的相互作用将决定哪些公司能够获得持续的市场领导地位。

医疗设备开发商和商业团队应优先采取行动，协调产品设计、证据产生和供应链弹性，以实现持续的竞争优势。

为了获得可持续的竞争优势，产业领导者应制定一系列切实可行的优先事项，将产品设计、临床检验、商业性执行和供应链韧性有机结合起来。首先，优先考虑可製造性设计和以使用者为中心的人体工学，以降低整体拥有成本，同时提高患者依从性和临床医生的接受度。其次，将可靠的真实世界证据计画纳入产品生命週期，以支持报销谈判，并展示产品在不同医疗环境中的长期疗效。第三，透过供应商多元化和考虑关键零件的近岸外包，减轻关税和物流中断的影响。

第四，制定针对门诊手术中心、长期照护机构和家庭照护服务提供者的推广计划，提供每位最终使用者独特工作流程的培训和支援。第五，与数位医疗服务提供者建立策略伙伴关係关係，以实现远端监测和结果追踪，从而增强支付方的价值提案。第六，在产品上市初期就调整监管策略，预测上市后监理要求，并儘可能设计符合多个司法管辖区要求的研究。最后，将永续性因素纳入产品生命週期规划，在环境影响和成本结构之间权衡一次性使用和可重复使用方案。这些建议旨在指导领导者进行重点投资，以提高产品采用率、管理风险并支持可扩展的成长。

我们采用了一种严谨的混合方法研究途径，结合了主要相关人员访谈、临床文献综合和三角证据检验，为策略决策提供资讯。

本执行摘要的调查方法结合了对主要临床文献的结构化回顾、对关键临床和商业相关人员的定性访谈，以及对监管和研发资讯的系统分析。主要资讯来源包括与泌尿系统和妇科临床医生、医院和长期护理网络的采购负责人以及产品开发专家的深入对话，以确保结论能够反映技术、临床和商业性观点。次要分析则纳入了同行评审期刊、监管指导文件、产品标籤和公司发布的临床试验摘要，以检验临床性能描述。

数据综合运用三角测量技术来协调不同的输入数据，并突显共识领域和新出现的争议。细分框架与临床路径和最终用户工作流程相匹配，以验证其对商业化决策的实际意义。品管包括将访谈见解与已记录的证据进行交叉检验，以及反覆的专家评审。对于仍存在不确定性的领域，调查方法会指出需要进一步进行针对性研究的主题，例如不同植入材料的长期疗效或耐久性比较。这种方法有助于对趋势进行可靠的解读，同时也能辨识出需要更深入研究的领域。

一项着眼于未来的整合计划，强调创新、循证实践和供应链韧性的策略协同，以最大限度地造福患者并实现商业性成功。

总之，尿失禁医疗器材领域正处于曲折点对于应对医疗设备实施的复杂性以及在不同医疗机构中扩大应用至关重要。

展望未来，相关人员应着重关注以下几个面向：产生高品质的结果数据、最大限度地减少供应链中断风险，以及设计能够解决病患和医护人员特定痛点的产品。有了这些优先事项，该行业就能继续提供改善生活品质的解决方案，同时满足现代医疗保健系统日益增长的期望。这个结论强调了深思熟虑的策略和严谨的执行对于掌握发展动能、推动永续成长的重要性。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧演算法整合到智慧型穿戴式尿失禁感测器中，用于即时监测漏尿情况
  • 微创神经调控植入在治疗顽固性尿失禁的应用日益广泛
  • 设备製造商与远端医疗平台合作，拓展远距尿失禁护理服务
  • 开发针对不同性别的骨盆底装置，以适应男性和女性患者之间的解剖结构差异
  • 为了解决消费者永续性的担忧，可生物降解和环保吸收性产品正在兴起。
  • 监管部门核准加速新型膀胱灌注疗法治疗应力性尿失禁的市场准入
  • 泌尿系统诊所与数位医疗公司建立策略合作伙伴关係，以加强患者依从性追踪
  • 对采用生物回馈疗法技术的家用骨盆底肌训练系统的投资激增
  • 拓展电子商务管道，以推广失禁护理产品的个人化订阅模式
  • 超音波填充剂输送系统的出现提高了尿道注射手术的准确性

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依设备类型分類的尿失禁设备市场

  • 外部设备
    • 导管
    • 收藏家和滴水收藏家
    • 阴茎夹
  • 内部设备
    • 人工尿道括约肌
    • 子宫托
    • 荐骨神经刺激器
    • 尿道插入器
    • 阴道吊带

9. 依材料分類的尿失禁器材市场

  • 乳胶
  • 聚合物基材料
  • 硅酮

第十章 按技术分類的尿失禁设备市场

  • 电刺激设备
  • 机械设备
  • 外科植入

11. 尿失禁治疗设备市场－性别

  • 女士
  • 男性

第十二章 尿失禁治疗设备市场（依类型划分）

  • 一次性的
  • 可重复使用的

第十三章 依年龄组别分類的尿失禁器械市场

  • 成人
  • 孩子们

第十四章 依应用分類的尿失禁器材市场

  • 功能性尿失禁
  • 溢出性尿失禁
  • 应力性尿失禁
  • 急性尿失禁

第十五章 依最终用户分類的尿失禁设备市场

  • 门诊手术中心
  • 居家照护环境
  • 医院和诊所
  • 长期照护机构

第十六章 尿失禁器械市场（依通路划分）

  • 医院药房
  • 线下药房
  • 线上销售

17. 各地区尿失禁治疗设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十八章 尿失禁器材市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十九章 各国尿失禁治疗设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第20章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Aeroflow Inc.
    • Amber Therapeutics
    • Attends Healthcare Products, Inc. by Domtar Corporation
    • Avanos Medical, Inc.
    • Avation Medical
    • B. Braun SE
    • Becton, Dickinson and Company
    • BioDerm, Inc.
    • Boston Scientific Corporation
    • Caldera Medical
    • Coloplast A/S
    • Contipi Medical
    • ConvaTec Group PLC
    • Essity AB
    • Hollister Incorporated
    • Johnson & Johnson Services Inc.
    • Kimberly-Clark Corporation
    • Laborie
    • Life360 Innovation, Inc.
    • Medtronic PLC
    • Olympus Corporation
    • Ontex Group NV
    • Pelvital USA Inc.
    • PROMEDON GmbH
    • Styker Corporation
    • Teleflex Incorporated
    • Watkins-Conti Products, Inc.
Product Code: MRR-034B50030353

The Urinary Incontinence Device Market is projected to grow by USD 6.22 billion at a CAGR of 7.60% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.46 billion
Estimated Year [2025] USD 3.71 billion
Forecast Year [2032] USD 6.22 billion
CAGR (%) 7.60%

A strategic framing of clinical unmet needs, evolving patient expectations, and the multidisciplinary priorities that should guide urinary incontinence device stakeholders

This executive summary opens with a focused introduction to the urinary incontinence device landscape, emphasizing the clinical burden, evolving patient expectations, and the strategic priorities that should guide industry stakeholders. The condition transcends age and gender boundaries, creating heterogeneous clinical presentations that demand a mix of conservative, minimally invasive, and implantable solutions. Across care pathways, clinicians seek devices that balance efficacy with patient comfort and long-term durability, while procurement and payer stakeholders increasingly value demonstrable outcomes and cost-effectiveness.

Given the rapid pace of device innovation and parallel advances in materials science and digital health, manufacturers and investors must view product development through a multidisciplinary lens. Clinical evidence generation, regulatory alignment, and reimbursement pathways together create the framework for sustainable adoption. In this context, an integrated approach that couples robust clinical validation with scalable manufacturing and differentiated distribution strategies will be essential. The introduction thus frames the rest of this summary by outlining the key domains where strategic focus can unlock value, including technology differentiation, targeted end-user engagement, and resilient supply chain design.

Transformative technological, demographic, and regulatory shifts that are redefining competitive advantage and adoption pathways for urinary incontinence devices

The landscape for urinary incontinence devices is undergoing several transformative shifts driven by converging technological, demographic, and policy forces. Advances in electrical stimulation, refinement of implantable materials, and miniaturization of mechanical components are elevating device performance while improving patient comfort. Concurrently, the rise of remote monitoring and integration with mobile health platforms is enabling longitudinal adherence tracking and real-world outcome capture, which in turn supports evidence-based reimbursement discussions.

Demographically, an aging population and broader demand for quality-of-life interventions are increasing the clinical imperative for reliable, user-friendly solutions. Regulatory agencies are also adapting pathways to balance timely patient access with rigorous safety evaluation, encouraging companies to invest in post-market surveillance and real-world evidence strategies. Moreover, supply chain resilience has moved to the top of executive agendas, prompting re-evaluation of single-source dependencies and fostering nearshoring conversations. Taken together, these shifts are redefining competitive advantage: companies that pair engineering excellence with data-driven outcomes, robust regulatory planning, and supply chain agility will lead the next wave of adoption.

How tariff policy shifts enacted in 2025 are reshaping sourcing, procurement strategy, and commercialization dynamics across the urinary incontinence device value chain

The cumulative impact of United States tariff changes implemented in 2025 presents material implications for the urinary incontinence device ecosystem, particularly for manufacturers that rely on cross-border supply chains for components, finished goods, or specialized materials. Increased tariff burdens can raise input costs, compress manufacturer margins, and prompt reconsideration of sourcing strategies. In response, procurement teams are likely to pursue nearshoring, dual sourcing, and renegotiated supplier contracts to mitigate exposure and preserve margin integrity.

Beyond direct cost effects, tariffs can influence strategic decision-making around product design and material selection, nudging developers toward alternatives that reduce reliance on tariff-affected imports. Distributors and healthcare providers may face pricing adjustments, which could slow purchasing cycles in cost-sensitive segments such as long-term care facilities and ambulatory centers. At the same time, policy shifts can create opportunities for domestic manufacturing investment, with potential to shorten lead times and improve quality oversight. Clinically, stakeholders must remain vigilant to ensure that cost-driven material substitutions do not compromise device safety or performance, and that regulatory filings reflect any design or supply chain changes. In sum, tariffs act as a catalyst for broader supply chain transformation, compelling stakeholders to align procurement strategy, clinical validation, and commercial planning to preserve access and value.

Integrated segmentation insights linking device type, material selection, technology modality, patient demographics, and distribution channels to clinical adoption and commercial strategy

Key segmentation insights reveal how product design, material science, technology modality, demographic targeting, usage patterns, and channel preferences intersect to shape clinical adoption and commercial opportunity. When devices are considered by type, the market divides between External Devices and Internal Devices, with External Devices encompassing catheters, collectors and drip collectors, and penile clamps while Internal Devices include artificial urinary sphincters, pessaries, sacral nerve stimulation devices, urethral inserts, and vaginal slings. Consideration of material choices highlights the continuing relevance of latex alongside polymer-based materials and silicone, each carrying distinct implications for biocompatibility, patient comfort, and manufacturing processes.

Technological segmentation separates electrical stimulation devices from mechanical devices and surgical implants, prompting differentiated clinical trial designs and surgeon training pathways. Gender-specific approaches remain essential, as female and male patients present differing anatomical and etiological profiles that influence device selection and outcomes. Form factors that distinguish disposable from reusable products affect procurement cycles, sterilization requirements, and environmental sustainability considerations. Age-group segmentation across adults and pediatric populations requires tailored safety and usability testing. Clinical application categorization into functional incontinence, overflow incontinence, stress incontinence, and urge continence drives both product specifications and clinical endpoints. Finally, end-user distinctions among ambulatory surgical centers, homecare settings, hospitals and clinics, and long-term care facilities intersect with distribution channel preferences, including hospital pharmacies, offline pharmacies, and online sales, to define route-to-customer strategies and post-market support requirements.

Regional dynamics across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine regulatory strategy, reimbursement alignment, and distribution prioritization

Regional dynamics exert a strong influence on regulatory environments, reimbursement systems, and supply chain architectures, shaping how companies prioritize investments and tailor go-to-market approaches. In the Americas, market participants face diverse payer landscapes and a high level of clinical specialization, which often necessitates clear outcome data, targeted KOL engagement, and flexible pricing frameworks. Moving across Europe, Middle East & Africa, stakeholders encounter a mosaic of regulatory requirements and reimbursement norms, where country-specific pathways and localized clinical evidence play decisive roles in adoption. In many parts of this region, partnerships with regional distributors and careful navigation of procurement cycles are critical to market entry.

Asia-Pacific presents a combination of rapid demographic change, varied regulatory maturity, and growing manufacturing capacity. The region's evolving healthcare infrastructure and rising emphasis on minimally invasive options create opportunities for novel device introductions, while local production capabilities can offer cost advantages and supply chain resilience. Across all regions, differences in end-user behavior, clinical practice patterns, and digital health readiness require that companies adopt a regionally nuanced commercial strategy that aligns product design, clinical evidence generation, and distribution partnerships with local stakeholder expectations.

Competitive dynamics, partnership models, and innovation pipelines that shape leadership trajectories and long-term differentiation in urinary incontinence therapeutics

Competitive dynamics among companies active in the urinary incontinence device arena continue to evolve, driven by product innovation, strategic partnerships, and differentiated commercialization models. Leading firms are investing in modular design strategies that enable iterative improvements while preserving regulatory continuity. Collaboration between device manufacturers and digital health providers is accelerating the development of integrated solutions that pair mechanical or implantable therapies with remote monitoring and adherence platforms, strengthening value propositions for payers and providers.

Mergers and strategic alliances remain an important route to scale, particularly where complementary portfolios or geographic footprints can be combined to optimize clinical support and distribution networks. Intellectual property portfolios centered on novel materials, stimulation algorithms, and minimally invasive delivery systems are important competitive moats. At the same time, smaller, innovation-focused entrants are contributing to an active pipeline of differentiated approaches, often leveraging focused clinical programs to prove value in niche indications before pursuing broader adoption. For commercial leaders, the interplay between product differentiation, evidence generation, and channel strategy will determine which companies achieve sustained market leadership.

Actionable priorities for device developers and commercial teams to synchronize product design, evidence generation, and supply resilience for sustained competitive advantage

Industry leaders should pursue a set of actionable priorities that align product design, clinical validation, commercial execution, and supply chain resilience to capture durable advantage. First, prioritize design-for-manufacturability and user-centric ergonomics to reduce total cost of ownership while improving patient adherence and clinician acceptance. Second, integrate robust real-world evidence plans into product lifecycles to support reimbursement negotiations and demonstrate longitudinal outcomes in diverse care settings. Third, diversify supplier bases and consider nearshoring for critical components to mitigate tariff exposure and logistical disruptions.

Fourth, develop targeted engagement programs for ambulatory surgical centers, long-term care facilities, and homecare providers, calibrating training and support to the unique workflows of each end user. Fifth, pursue strategic partnerships with digital health providers to enable remote monitoring and outcome tracking that strengthen payer value propositions. Sixth, align regulatory strategies early in development, anticipating post-market surveillance requirements and designing studies that satisfy multiple jurisdictions when feasible. Finally, embed sustainability considerations into product lifecycle planning, balancing disposable and reusable options against environmental impact and cost structures. These recommendations collectively guide leaders to make focused investments that improve adoption, manage risk, and support scalable growth.

A rigorous mixed-methods research approach that blends primary stakeholder interviews, clinical literature synthesis, and triangulated evidence validation to inform strategic decision-making

The research methodology underpinning this executive summary combined a structured review of primary clinical literature, qualitative interviews with key clinical and commercial stakeholders, and systematic analysis of regulatory and policy developments. Primary inputs included in-depth conversations with clinicians across urology and gynecology, procurement leaders from hospitals and long-term care networks, and product development experts, ensuring that technical, clinical, and commercial perspectives informed the conclusions. Secondary analysis incorporated peer-reviewed journals, regulatory guidance documents, product labeling, and company-published clinical trial summaries to validate clinical performance narratives.

Data synthesis employed triangulation techniques to reconcile divergent inputs and highlight consensus areas versus emerging debates. Segmentation frameworks were mapped to clinical pathways and end-user workflows to ensure practical relevance for commercialization decision-making. Quality control included cross-validation of interview insights against documented evidence and iterative review cycles with subject-matter experts. Where uncertainties remained, the methodology flagged topics that require further targeted study, such as long-term comparative effectiveness and durability across differing implantable materials. This approach supports confident interpretation of trends while acknowledging areas that demand deeper investigation.

A forward-looking synthesis emphasizing the strategic alignment of innovation, evidence generation, and supply resilience to maximize patient benefit and commercial success

In conclusion, the urinary incontinence device environment is at an inflection point where technological advances, changing payer expectations, and supply chain realignment converge to create both challenges and opportunities. Companies that align product innovation with pragmatic evidence strategies, resilient sourcing, and tailored regional execution will be well positioned to translate clinical capability into meaningful patient impact. Cross-functional collaboration across clinical, regulatory, and commercial teams is essential to navigate the complexities of device introduction and scale adoption across diverse care settings.

Moving forward, stakeholder attention should focus on generating high-quality outcome data, minimizing exposure to supply chain disruptions, and designing products that address specific patient and provider pain points. With these priorities in place, the sector can continue to deliver solutions that improve quality of life while meeting the rigorous expectations of modern healthcare systems. The conclusion underscores the importance of deliberate strategy and disciplined execution to capitalize on momentum and drive sustainable growth.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI algorithms in smart wearable incontinence sensors for real-time leakage monitoring
  • 5.2. Rising adoption of minimally invasive nerve modulation implants for refractory urinary incontinence management
  • 5.3. Collaboration between device manufacturers and telehealth platforms to expand remote continence care services
  • 5.4. Development of gender-specific pelvic floor devices tailored to anatomical differences in male and female patients
  • 5.5. Growth in biodegradable and eco-friendly absorbent products to address sustainability concerns among users
  • 5.6. Regulatory approvals accelerating market entry of novel bladder instillation therapies for stress incontinence
  • 5.7. Strategic partnerships between urology clinics and digital health firms to enhance patient adherence tracking
  • 5.8. Investment surge in at-home pelvic floor muscle training systems with integrated biofeedback technology
  • 5.9. Expansion of e-commerce channels driving personalized subscription models for continence care supplies
  • 5.10. Emergence of ultrasound-guided bulking agent delivery systems improving precision in urethral injection procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urinary Incontinence Device Market, by Device Type

  • 8.1. External Devices
    • 8.1.1. Catheters
    • 8.1.2. Collectors & Drip Collectors
    • 8.1.3. Penile Clamps
  • 8.2. Internal Devices
    • 8.2.1. Artificial Urinary Sphincters
    • 8.2.2. Pessaries
    • 8.2.3. Sacral Nerve Stimulation Devices
    • 8.2.4. Urethral Inserts
    • 8.2.5. Vaginal Slings

9. Urinary Incontinence Device Market, by Material

  • 9.1. Latex
  • 9.2. Polymer-based Materials
  • 9.3. Silicone

10. Urinary Incontinence Device Market, by Technology

  • 10.1. Electrical Stimulation Devices
  • 10.2. Mechanical Devices
  • 10.3. Surgical Implants

11. Urinary Incontinence Device Market, by Gender

  • 11.1. Female
  • 11.2. Male

12. Urinary Incontinence Device Market, by Form

  • 12.1. Disposable
  • 12.2. Reusable

13. Urinary Incontinence Device Market, by Age Group

  • 13.1. Adult
  • 13.2. Pediatrics

14. Urinary Incontinence Device Market, by Application

  • 14.1. Functional Incontinence
  • 14.2. Overflow Incontinence
  • 14.3. Stress Incontinence
  • 14.4. Urge Continence

15. Urinary Incontinence Device Market, by End User

  • 15.1. Ambulatory Surgical Centers
  • 15.2. Homecare Settings
  • 15.3. Hospitals & Clinics
  • 15.4. Long-Term Care Facilities

16. Urinary Incontinence Device Market, by Distribution Channel

  • 16.1. Hospital Pharmacy
  • 16.2. Offline Pharmacy
  • 16.3. Online Sales

17. Urinary Incontinence Device Market, by Region

  • 17.1. Americas
    • 17.1.1. North America
    • 17.1.2. Latin America
  • 17.2. Europe, Middle East & Africa
    • 17.2.1. Europe
    • 17.2.2. Middle East
    • 17.2.3. Africa
  • 17.3. Asia-Pacific

18. Urinary Incontinence Device Market, by Group

  • 18.1. ASEAN
  • 18.2. GCC
  • 18.3. European Union
  • 18.4. BRICS
  • 18.5. G7
  • 18.6. NATO

19. Urinary Incontinence Device Market, by Country

  • 19.1. United States
  • 19.2. Canada
  • 19.3. Mexico
  • 19.4. Brazil
  • 19.5. United Kingdom
  • 19.6. Germany
  • 19.7. France
  • 19.8. Russia
  • 19.9. Italy
  • 19.10. Spain
  • 19.11. China
  • 19.12. India
  • 19.13. Japan
  • 19.14. Australia
  • 19.15. South Korea

20. Competitive Landscape

  • 20.1. Market Share Analysis, 2024
  • 20.2. FPNV Positioning Matrix, 2024
  • 20.3. Competitive Analysis
    • 20.3.1. Aeroflow Inc.
    • 20.3.2. Amber Therapeutics
    • 20.3.3. Attends Healthcare Products, Inc. by Domtar Corporation
    • 20.3.4. Avanos Medical, Inc.
    • 20.3.5. Avation Medical
    • 20.3.6. B. Braun SE
    • 20.3.7. Becton, Dickinson and Company
    • 20.3.8. BioDerm, Inc.
    • 20.3.9. Boston Scientific Corporation
    • 20.3.10. Caldera Medical
    • 20.3.11. Coloplast A/S
    • 20.3.12. Contipi Medical
    • 20.3.13. ConvaTec Group PLC
    • 20.3.14. Essity AB
    • 20.3.15. Hollister Incorporated
    • 20.3.16. Johnson & Johnson Services Inc.
    • 20.3.17. Kimberly-Clark Corporation
    • 20.3.18. Laborie
    • 20.3.19. Life360 Innovation, Inc.
    • 20.3.20. Medtronic PLC
    • 20.3.21. Olympus Corporation
    • 20.3.22. Ontex Group NV
    • 20.3.23. Pelvital USA Inc.
    • 20.3.24. PROMEDON GmbH
    • 20.3.25. Styker Corporation
    • 20.3.26. Teleflex Incorporated
    • 20.3.27. Watkins-Conti Products, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 17. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 19. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. EUROPE URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. MIDDLE EAST URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. AFRICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. ASIA-PACIFIC URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. ASEAN URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. GCC URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. EUROPEAN UNION URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. BRICS URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 34. G7 URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 35. NATO URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 36. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 37. URINARY INCONTINENCE DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 38. URINARY INCONTINENCE DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. URINARY INCONTINENCE DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY COLLECTORS & DRIP COLLECTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PENILE CLAMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ARTIFICIAL URINARY SPHINCTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PESSARIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SACRAL NERVE STIMULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URETHRAL INSERTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY VAGINAL SLINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LATEX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY POLYMER-BASED MATERIALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SILICONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MECHANICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FEMALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY MALE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY PEDIATRICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY FUNCTIONAL INCONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OVERFLOW INCONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY STRESS INCONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY URGE CONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY OFFLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL URINARY INCONTINENCE DEVICE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY EXTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY INTERNAL DEVICES, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY GENDER, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. LATIN AMERICA URINARY INCONTINENCE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 298. LATIN AMERICA URIN